Fate Therapeutics FATE has outperformed the market over the past 5 years by 64.83% on an annualized basis.
Buying $100 In FATE: 5 years ago, an investor could have purchased 35.34 shares of Fate Therapeutics at the time with $100. This investment in FATE would have produced an average annual return of 80.91%. Currently, Fate Therapeutics has a market capitalization of $5.29 billion.
Fate Therapeutics's Share Price Over Last 5 Years
If you had invested $100 in Fate Therapeutics you would have approximately $1,958.30 today.
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
You can check out Benzinga's market data in an enhanced view on Benzinga Pro
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.